Obesity and endothelial function
M Kajikawa, Y Higashi - Biomedicines, 2022 - mdpi.com
Obesity is a major public health problem and is related to increasing rates of cardiovascular
morbidity and mortality. Over 1.9 billion adults are overweight or obese worldwide and the …
morbidity and mortality. Over 1.9 billion adults are overweight or obese worldwide and the …
Cardiovascular and renal effectiveness of GLP-1 receptor agonists vs. other glucose-lowering drugs in type 2 diabetes: a systematic review and meta-analysis of real …
I Caruso, A Cignarelli, GP Sorice, A Natalicchio… - Metabolites, 2022 - mdpi.com
Cardiovascular outcome trials (CVOT) showed that treatment with glucagon-like peptide-1
receptor agonists (GLP-1RA) is associated with significant cardiovascular benefits …
receptor agonists (GLP-1RA) is associated with significant cardiovascular benefits …
Impact of semaglutide on high-sensitivity C-reactive protein: exploratory patient-level analyses of SUSTAIN and PIONEER randomized clinical trials
O Mosenzon, MS Capehorn, A De Remigis… - Cardiovascular …, 2022 - Springer
Background Exploratory analysis to determine the effect of semaglutide versus comparators
on high-sensitivity C-reactive protein (hsCRP) in subjects with type 2 diabetes. Methods …
on high-sensitivity C-reactive protein (hsCRP) in subjects with type 2 diabetes. Methods …
Endothelial progenitor cells as biomarkers of diabetes-related cardiovascular complications
J Benítez-Camacho, A Ballesteros… - Stem Cell Research & …, 2023 - Springer
Diabetes mellitus (DM) constitutes a chronic metabolic disease characterized by elevated
levels of blood glucose which can also lead to the so-called diabetic vascular complications …
levels of blood glucose which can also lead to the so-called diabetic vascular complications …
Liraglutide improves myocardial perfusion and energetics and exercise tolerance in patients with type 2 diabetes
A Chowdhary, S Thirunavukarasu, T Joseph… - Journal of the American …, 2024 - jacc.org
Abstract Background Type 2 diabetes (T2D) is characterized by insulin resistance (IR) and
dysregulated insulin secretion. Glucagon-like peptide-1 receptor agonist liraglutide …
dysregulated insulin secretion. Glucagon-like peptide-1 receptor agonist liraglutide …
Restoration of blood vessel regeneration in the era of combination SGLT2i and GLP-1RA therapy for diabetes and obesity
Ischaemic cardiovascular diseases, including peripheral and coronary artery disease,
myocardial infarction, and stroke, remain major comorbidities for individuals with type 2 …
myocardial infarction, and stroke, remain major comorbidities for individuals with type 2 …
Pleiotropic effects of GLP‐1 receptor agonists on peripheral artery disease: Is there any hope?
P Caruso, MI Maiorino, G Bellastella… - Diabetes …, 2023 - search.ebscohost.com
Cardiovascular disease, diabetic foot, GLP1-RA, peripheral artery disease, type 2 diabetes
The need of new data on peripheral circulation is clearly growing and is reflected by the …
The need of new data on peripheral circulation is clearly growing and is reflected by the …
[HTML][HTML] Liraglutide alleviates myocardial ischemia‒reperfusion injury in diabetic mice
B Fang, F Liu, X Yu, J Luo, X Zhang, T Zhang… - Molecular and Cellular …, 2023 - Elsevier
Diabetic patients are prone to acute myocardial infarction. Although reperfusion therapy can
preserve the viability of the myocardium, it also causes fatal ischemia‒reperfusion injury …
preserve the viability of the myocardium, it also causes fatal ischemia‒reperfusion injury …
Evaluation of antiobesity and hepatorenal protective activities of Salvia officinalis extracts pre-treatment in high-fat diet-induced obese rats
The present study evaluated the effects of Hail Salvia officinalis total extract (SOTE) and its
high flavonoid fraction (SOHFF) on the high-fat diet (HFD)-induced obesity and hepatorenal …
high flavonoid fraction (SOHFF) on the high-fat diet (HFD)-induced obesity and hepatorenal …
Chemical characterization and DPP-IV inhibitory activity evaluation of tripeptides from Gynura divaricata (L.) DC.
X Ye, L Xiong, Q Fu, B Wang, Y Wang, K Zhang… - Journal of …, 2022 - Elsevier
Ethnopharmacological relevance Gynura divaricata (L.) DC.(GD), a herbal medicine, has
been used for the prevention and treatment of hyperglycemia in China. However …
been used for the prevention and treatment of hyperglycemia in China. However …